Keyword: Vitrakvi

Eli Lilly

7. Eli Lilly/Loxo Oncology

Eli Lilly’s $8 billion takeover of Loxo Oncology was one of several mergers and acquisitions focused on cancer treatments and is the Indianapolis drugmaker’s largest bet in the field. The $235-per-share price marked a decent 68% premium over Loxo’s previous close.